These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10703073)

  • 1. [Serum p53 antibody assay: evaluation in colorectal cancer].
    Hammel P; Soussi T
    Rev Med Interne; 2000 Feb; 21(2):167-73. PubMed ID: 10703073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of serum anti-P53 antibodies from patients with colorectal cancer in China using a combination of P53- and phage-ELISA: correlation to clinical parameters.
    Wu J; Qiu T; Pan P; Yu D; Ju Z; Qu X; Gao X; Mao C; Wang L
    Asian Pac J Cancer Prev; 2011; 12(11):2921-4. PubMed ID: 22393964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Value of Serum p53 Antibody in the Diagnosis and Prognosis of Colorectal Cancer.
    Kunizaki M; Sawai T; Takeshita H; Tominaga T; Hidaka S; To K; Miyazaki T; Hamamoto R; Nanashima A; Nagayasu T
    Anticancer Res; 2016 Aug; 36(8):4171-5. PubMed ID: 27466527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Significance of Combined Measurement of p53 Antibody and other Tumor Markers for Colorectal Cancer after Curative Resection.
    Kawahara D; Fujita F; Hayashi H; Matsuyama T; Eguchi S
    Hepatogastroenterology; 2015 May; 62(139):624-8. PubMed ID: 26897942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 and follow-up of colorectal adenocarcinomas.
    Polge A; Bourgaux JF; Bancel E; Pignodel C; Boyer JC; Poirey S; de Bornier BM; Balmes JL; Bali JP
    Dig Dis Sci; 1998 Jul; 43(7):1434-42. PubMed ID: 9690377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic alteration of p53, but not overexpression of intratumoral p53 protein, or serum p53 antibody is a prognostic factor in sporadic colorectal adenocarcinoma.
    Chang SC; Lin JK; Lin TC; Liang WY
    Int J Oncol; 2005 Jan; 26(1):65-75. PubMed ID: 15586226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediagnostic Antibodies to Serum p53 and Subsequent Colorectal Cancer.
    Teras LR; Gapstur SM; Maliniak ML; Jacobs EJ; Gansler T; Michel A; Pawlita M; Waterboer T; Campbell PT
    Cancer Epidemiol Biomarkers Prev; 2018 Feb; 27(2):219-223. PubMed ID: 29254936
    [No Abstract]   [Full Text] [Related]  

  • 8. Detection and monitoring of serum p53 antibodies in patients with colorectal cancer.
    Hammel P; Boissier B; Chaumette MT; Piedbois P; Rotman N; Kouyoumdjian JC; Lubin R; Delchier JC; Soussi T
    Gut; 1997 Mar; 40(3):356-61. PubMed ID: 9135525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral immune response to p53 correlates with clinical course in colorectal cancer patients during adjuvant chemotherapy.
    Lechpammer M; Lukac J; Lechpammer S; Kovacević D; Loda M; Kusić Z
    Int J Colorectal Dis; 2004 Mar; 19(2):114-20. PubMed ID: 14634775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic significance in serum presence of anti-p53 antibody in patients with colorectal carcinoma.
    Nozoe T; Yasuda M; Honda M; Inutsuka S; Korenaga D
    Hepatogastroenterology; 2007; 54(77):1422-5. PubMed ID: 17708268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating p53 antibody in patients with colorectal cancer: relation to clinicopathologic features and survival.
    Shiota G; Ishida M; Noguchi N; Oyama K; Takano Y; Okubo M; Katayama S; Tomie Y; Harada K; Hori K; Ashida K; Kishimoto Y; Hosoda A; Suou T; Kanbe T; Tanaka K; Nosaka K; Tanida O; Kojo H; Miura K; Ito H; Kaibara N; Kawasaki H
    Dig Dis Sci; 2000 Jan; 45(1):122-8. PubMed ID: 10695624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical significance of serum p53 antibody detection in a chemosensitivity assay in cases of human colorectal cancer].
    Takeda A; Shimada H; Nakajima K; Imaseki H; Okazumi S; Takayama W; Iwasaki K; Makino H; Natsume T; Kouno T; Kondo S; Suzuki T; Ochiai T; Isono K
    Gan To Kagaku Ryoho; 2000 Jun; 27(6):879-83. PubMed ID: 10897215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical utility of anti-p53 auto-antibody: systematic review and focus on colorectal cancer.
    Suppiah A; Greenman J
    World J Gastroenterol; 2013 Aug; 19(29):4651-70. PubMed ID: 23922463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simplified approaches for the development of an ELISA to detect circulating autoantibodies to p53 in cancer patients.
    Cressey R; Pimpa S; Chewaskulyong B; Lertprasertsuke N; Saeteng S; Tayapiwatana C; Kasinrerk W
    BMC Biotechnol; 2008 Feb; 8():16. PubMed ID: 18284706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Significance of Serum p53 Antibody in the Early Detection and Poor Prognosis of Gastric Cancer.
    Kunizaki M; Fukuda A; Wakata K; Tominaga T; Nonaka T; Miyazaki T; Matsumoto K; Sumida Y; Hidaka S; Yasutake T; Sawai T; Hamamoto R; Nanashima A; Nagayasu T
    Anticancer Res; 2017 Apr; 37(4):1979-1984. PubMed ID: 28373470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a multiplexed tumor-associated autoantibody-based blood test for the detection of colorectal cancer.
    Fan CW; Kuo YB; Lin GP; Chen SM; Chang SH; Li BA; Chan EC
    Clin Chim Acta; 2017 Dec; 475():157-163. PubMed ID: 29074220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of serum p53 antibodies in mucosal colorectal cancer and negative conversion after endoscopic resection.
    Takeda A; Nakajima K; Shimada H; Imazeki H; Takayama W; Hayashi H; Yoshimura S; Suzuki T; Ochiai T; Isono K
    J Clin Gastroenterol; 1999 Mar; 28(2):153-4. PubMed ID: 10078825
    [No Abstract]   [Full Text] [Related]  

  • 18. Anti-p53 autoantibody in colorectal cancer: prognostic significance in long-term follow-up.
    Suppiah A; Alabi A; Madden L; Hartley JE; Monson JR; Greenman J
    Int J Colorectal Dis; 2008 Jun; 23(6):595-600. PubMed ID: 18330580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlations between p53-protein accumulation, serum antibodies and gene mutation in colorectal cancer.
    Hammel P; Leroy-Viard K; Chaumette MT; Villaudy J; Falzone MC; Rouillard D; Hamelin R; Boissier B; Remvikos Y
    Int J Cancer; 1999 May; 81(5):712-8. PubMed ID: 10328221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutant p53 protein in serum could be used as a molecular marker in human breast cancer.
    Balogh GA; Mailo DA; Corte MM; Roncoroni P; Nardi H; Vincent E; Martinez D; Cafasso ME; Frizza A; Ponce G; Vincent E; Barutta E; Lizarraga P; Lizarraga G; Monti C; Paolillo E; Vincent R; Quatroquio R; Grimi C; Maturi H; Aimale M; Spinsanti C; Montero H; Santiago J; Shulman L; Rivadulla M; Machiavelli M; Salum G; Cuevas MA; Picolini J; Gentili A; Gentili R; Mordoh J
    Int J Oncol; 2006 Apr; 28(4):995-1002. PubMed ID: 16525651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.